PharmiWeb

Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Yahoo Finance

The Worldwide Continuous Subcutaneous Insulin Infusion Industry is Expected to Reach $4.25 Billion by 2027: Rising Awareness of Advanced Insulin Delivery Devices Drives Growth

Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Subcutaneous Insulin Infusion Market (2022-2027) by Products, Patient Type, End-Uses, and Geography, Competitive Analysis and the ...
Healio

Cutaquig enables modified subcutaneous immunoglobulin infusion regimens

SAN ANTONIO — Cutaquig provided safe and effective dosing flexibility for patients with primary immunodeficiency disease, according to data presented at the American Academy of Allergy, Asthma & ...
Healio

Continuous subcutaneous insulin infusion system improves quality of life

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes reported improved quality of life and glycemic control when using a continuous ...
Nature

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma

Metastatic renal cell carcinoma (mRCC) carries a poor prognosis. The response rate to chemotherapy is low and responses are of short duration (Heinzer et al, 2001). Immunotherapeutic agents are more ...
Yahoo Finance

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

MAHWAH, N.J., February 06, 2025--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, ...
Business Wire

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

MAINZ, Germany, & MAHWAH, N.J.--(BUSINESS WIRE)--SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, and KORU Medical Systems (NASDAQ: KRMD), a leading medical ...
ascopubs.org

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers

Median duration of daratumumab (DARA) administration for treatment of multiple myeloma is 3-7 hours for the intravenous formulation (DARA IV) and 3-5 minutes for the subcutaneous formulation (DARA SC) ...
Medscape

What Should I Know About Using Hypodermoclysis in Geriatric Patients?

Is hypodermoclysis used for short-term hydration in geriatric patients in the nursing home setting? What are the specific procedures and policies being used? Dehydration commonly occurs in elderly ...
Business Wire

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion ...

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and ...
Nasdaq

KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion

KORU Medical Systems, Inc. KRMD has made a strategic move in its pursuit of expanding its footprint in the realm of large-volume subcutaneous infusion. The company announced a collaboration with a ...